News
1mon
ExtremeTech on MSNScientists Identify Antibodies That Neutralize the Virus Behind COVID-19With this piece of the virus in the body, the immune system learns to manufacture antibodies that work against the virus, ...
“No one thought it would work. In fact, it was common knowledge that it wouldn’t work. Antibodies would never be therapeutic agents,” said Levy. However, one of the most memorable moments happened ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
11h
The Healthy @Reader's Digest on MSNWhat Is Allergy Immunotherapy, and Does It Work?Allergy medications not doing the job this season? Experts explain why allergy immunotherapy may be the newest answer to ...
Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.
A super-resolution microscopy technique offers an unparalleled glimpse into how monoclonal antibodies bind to their targets ...
Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have ...
9d
News-Medical.Net on MSNSupercharging Next-Gen Antibody Discovery with AI and High-Throughput ExperimentationAutomation and machine learning are transforming antibody discovery at LabGenius, with the EVA™ platform enabling rapid, high ...
1d
News-Medical.Net on MSNNew insights into how myasthenia gravis antibodies disrupt muscle functionPeople who suffer from the autoimmune disease myasthenia gravis experience muscle weakness that can affect any of the muscles we use to blink, smile or even move our body around.
CEO of ImmunoPrecise Antibodies. "With the purchase order secured and work already underway, we are actively leveraging our proprietary B-cell Select™ platform and LENS ai ™ technology to ...
U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer ...
Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results